On the recordMarch 29, 2023
I am concerned that the lack of face-to-face meetings may be negatively affecting the FDA's ability to keep pace and retain its scientific and regulatory stature as the gold standard.
Source
congress.govI am concerned that the lack of face-to-face meetings may be negatively affecting the FDA's ability to keep pace and retain its scientific and regulatory stature as the gold standard.
Expresses concern over the impact of reduced meetings on FDA's effectiveness.
Share
More from Susan Collins
This incident shows how imperative it is that we have a mandate for body-worn cameras.
I spoke with Mullin last night and asked him to halt all nonurgent vehicle stops by ICE.